Streetbeat News

Regulatory

ATVI

EWU

MSFT

Microsoft has proposed a small divestiture to address the concerns of the UK's Competition and Markets Authority (CMA) regarding its acquisition of Activision Blizzard.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 5:06 pm

TNDM

Tandem Diabetes Care has received FDA clearance for its Tandem Mobi insulin pump, leading to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:51 pm

GSK

NNVC

PFE

NanoViricides Inc (NNVC) shares are trading higher after the company reported positive preclinical data for its antiviral clinical drug candidate NV-387 for Respiratory Syncytial Virus (RSV). NV-387 is also the active ingredient of NV-CoV-2, the company's drug for COVID. The company plans to advance NV-387 into Phase 2 studies against RSV once the current Phase 1 studies of NV-CoV-2 are completed. GSK plc's (GSK) Arexvy and Pfizer Inc's (PFE) Abrysvo have recently been approved for RSV prophylaxis.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 4:51 pm

TNDM

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has received FDA clearance for the Tandem Mobi insulin pump for people with diabetes age 6 and up. The Tandem Mobi is fully controllable from a mobile app and is the world's smallest durable automated insulin delivery system. A limited release of Tandem Mobi is expected to start in late 2023 with full commercial availability planned in early 2024.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 4:50 pm

ADIL

Adial Pharmaceuticals Inc's shares are trading higher after the company provided a summary of feedback from recent meetings with U.S. and EU regulators and an update on its clinical development plan. The regulators confirmed the primary U.S. endpoint and acknowledged the results from the Phase 2 and Phase 3 post hoc analysis. The FDA agreed to Adial's plan to comply with ICH E1A by adding a long-term safety follow-up to the planned Phase 3 trial. The company expects to register AD04 with the FDA in Q3 of 2025, with an approximate cost of $25 million.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 4:48 pm

BTCUSD

The U.S. Securities and Exchange Commission (SEC) is asserting its authority over the crypto industry, causing uncertainty and legal challenges. The SEC has sued major crypto exchanges and impeded the establishment of a Bitcoin exchange-traded fund. Republicans propose to limit the SEC's discretion and shift oversight to the Commodity Futures Trading Commission (CFTC). However, the proposal faces opposition from Democrats, and the chances of it becoming law are slim without substantial Democratic support.

Portfolio Pulse from Murtuza Merchant

July 11, 2023 | 4:25 pm

AJRD

LHX

LMT

US Senator Elizabeth Warren and three other lawmakers have warned against the merger deal between L3Harris Technologies Inc (LHX) and Aerojet Rocketdyne Holdings, Inc. (AJRD), urging the Defense Department to thoroughly review the $4.7 billion deal. Lockheed Martin Corp's (LMT) COO, Frank St John, expressed concerns over access to rocket motors, fair pricing, and IP protections. The lawmakers also noted that Lockheed Martin, Raytheon, and Boeing are dependent on products that only Aerojet can produce.

Portfolio Pulse from Akanksha Bakshi

July 11, 2023 | 4:09 pm

AAVEUSD

Aave Companies, a key contributor to the Aave decentralized finance lending protocol, plans to launch the decentralized stablecoin GHO as an ERC-20 token on the Ethereum mainnet. The proposal, currently under review, could generate additional revenue for the Decentralized Autonomous Organization (DAO) and make stablecoin borrowing on the Aave Protocol more competitive. Voting is set to start today and conclude on July 14.

Portfolio Pulse from Murtuza Merchant

July 11, 2023 | 4:06 pm

BAC

Bank of America Corporation (NYSE:BAC) has been fined $90 million by the Consumer Financial Protection Bureau (CFPB) and $60 million by The Office of the Comptroller of the Currency (OCC) for illegal practices including charging junk fees, withholding credit card rewards, and opening fake accounts. The bank will pay over $100 million to affected consumers and $150 million in penalties to CFPB and OCC.

Portfolio Pulse from Nabaparna Bhattacharya

July 11, 2023 | 4:01 pm

NVO

The European Medicines Agency has extended its review of Novo's drugs Ozempic, Saxenda, and Wegovy, which started on 3 July 2023, to include other GLP-1 receptor agonists.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 3:47 pm